CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale CEO sold 37,656 shares at $0.60 ($22,556)
- 4 Open-market sale Chief Financial Officer sold 8,551 shares at $0.60 ($5,122)
- 4 Open-market sale Chief Medical Officer sold 4,025 shares at $0.60 ($2,411)
- 4 Open-market sale General Counsel sold 10,203 shares at $0.60 ($6,112)
- 4 Open-market sale SVP, Chief Scientific Officer sold 19,512 shares at $0.60 ($11,688)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
Page 6 of 41 · 801 filings